Friday, May 27 2022 | Time 18:12 Hrs(IST)
image
Business EconomyPosted at: Jan 20 2022 11:46AM


Glenmark, Lotus enter into exclusive licensing agreement for Ryaltris

Mumbai, Jan 20 (UNI) Pharmaceutical firm Glenmark Pharmaceuticals on Thursday said its Swiss subsidiary has entered into an agreement with a wholly-owned subsidiary of Lotus Pharmaceutical, for commercialising its innovative nasal spray Ryaltris in Singapore, Hong Kong and Vietnam.
Glenmark's Swiss subsidiary, Glenmark Specialty and Lotus' wholly owned subsidiary Lotus International have entered into an exclusive licensing agreement for commercialising its innovative nasal spray Ryaltris in Singapore, Hong Kong and Vietnam, the company said in a statement.
Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris, whereas Lotus will be responsible for commercialization of Ryaltris (subject to receipt of regulatory approvals), in these markets.
Glenmark will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus, the company said.
“We are excited to partner with Lotus for Ryaltris as it is a strong and reputed player in the region and is aligned with Glenmark’s objective to provide quality novel products to fulfill unmet needs of patients with allergic rhinitis.
This partnership will provide patients access to a highly effective and proven treatment for allergic rhinitis in these key South-East Asian markets,” Glenmark Pharmaceuticals Chief Commercial Officer Robert Crockart said.
Commenting on the development, Lotus Chief Executive Officer Petar Vazharov said, “As being strongly committed to making a difference for all patients, we are honored to partner with Glenmark to ensure this novel spray drug accessible to patients in South East Asia.
This is also the first Brand product to be included in our respiratory portfolio with strong clinical data and IP protection. The partnership not only strengthens the competitiveness of our overall product portfolio but also accelerates our expansion in key SEA countries.”
UNI PSK GNK
Please log in to get detailed story.
Tags: #Glenmark# Lotus enter into exclusive licensing agreement for Ryaltris
More News

JSW Steel net profit in Q4 dips 20 pc, revenue surges 74 pc

27 May 2022 | 6:00 PM

Mumbai, May 27 (UNI) Billionaire Sajjan Jindal-led JSW Steel on Friday reported 20% decline in consolidated net profit at Rs 3,343 crore in quarter ending March 2022 (Q4FY22) as compared to Rs 4,191 crore in the corresponding period in previous financial year.

see more..

Raminfo reports net profit of Rs 1 74 cr in Q4 FY22

27 May 2022 | 5:17 PM

Hyderabad, May 27 (UNI) India’s leading technology solutions provider Raminfo on Friday reported a net profit of 1.74 crore in the fourth quarter ended March 31, 2022 as against Rs 1.10 crore in the corresponding quarter in the previous financial year.

see more..

Kottayam-Kochi Rubber Market Rates

27 May 2022 | 5:14 PM

Kottayam, May 27 (UNI) Following were the Rubber Market rates announced by the Rubber Board here on Friday per quintal:
KOTTAYAM
RSS FOUR: 17450
RSS FIVE : 17300
ISNR TWENTY: 17000
SIXTY PERCENT LATEX: 12365
KOCHI
RSS FOUR : 17450
RSS FIVE : 17300
INTERNATIOAL RATES (BANGKOK)
RSS One : 17420
RSS Two : 17284
RSS Three: 17160
RSS Four : 17092
RSS Five : 16990
KUALALUMPUR
SMR TWENTY : 12890($166.05)
SIXTY PERCENT LATEX : 12180($156.90)
UNI PA RJ.

see more..
Sensex surges 632 13 pts

Sensex surges 632 13 pts

27 May 2022 | 4:58 PM

Mumbai, May 27 (UNI) The BSE Sensex on Friday added another gains 632.13 pts to close strong at 54,884.66 following gains in IT, Technology, Capital Goods and Finance stocks.

see more..

Tech Mahindra up 4 10 pc to Rs 1,123 55

27 May 2022 | 4:36 PM

Mumbai, May 27 (UNI) Tech Mahindra on Friday surged 4.10 per cent to Rs 1,123.55, a major gainer in the 30 scrips of the Bombay Stock Exchange (BSE).

see more..
image